| Name | astragaloside IV |
|---|---|
| Synonyms |
Astragalus Polysaccharides
Astragalus methylside b-D-Glucopyranoside, (3b,6a,16b,24R)-20,24-oxy-16,25-dihydroxy-3-(b-D-xylopyranosyloxy)-9,19-cyclolanostan-6-yl astragalus polysacchide concentrated extract Astragaloside A (Astramembrannin I Astragaloside IV beta-D-Glucopyranoside, (3beta,6alpha,16beta,24R)-20,24-oxy-16,25-dihydroxy-3-(beta-D-xylopyranosyloxy)-9,19-cyclolanostan-6-yl ASTRAGALOSIDE IV(P) Astramembrannin i Astragalin A Astragaloside A //BP Astrasieversianin XIV β-D-Glucopyranoside, (3β,6α,16β,24R)-20,24-oxy-16,25-dihydroxy-3-(β-D-xylopyranosyloxy)-9,19-cyclolanostan-6-yl Astragaloside IV CRS Astragaloside A, 10 mM in DMSO cyclosiversioside F ASTRAGALOSIDE (2R,3R,4S,5S,6R)-2-(((2,3R,4S,5aS,5bS,7S,7,9S,11,12aS)-4-Hydroxy-3-((2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)-2a,5a,8,8-tetramethyl-9-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)hexadecahydrocyclopenta[a]cyclopropa[e]phenanthren-7-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol Astragaloside IV-Astragaloside A Astragaloside A(Astragaloside IV) astragaloside A cyclosieversioside F Astragaloside IV(A) (3β,6α,9β,16β,20R,24S)-16,25-Dihydroxy-3-(β-D-xylopyranosyloxy)-20,24-epoxy-9,19-cyclolanostan-6-yl β-D-glucopyranoside ASTRAGALOSIDE IV(RG) Astragalus Extract Astragaloside IV β-D-Glucopyranoside, (3β,6α,9β,16β,20R,24S)-20,24-epoxy-16,25-dihydroxy-3-(β-D-xylopyranosyloxy)-9,19-cyclolanostan-6-yl |
| Description | Astragaloside A is one of the major active constituents of Astragalus membranaceus in Traditional Chinese Medicine; has been widely used to treat ischemic diseases.IC50 value: Target: in vitro: AS-IV treatment promotes umbilical vein endothelial cells (HUVEC) proliferation, migration, and tube formation. AS-IV treatment also activates JAK2/STAT3 and ERK1/2 signaling pathways, and up-regulates endothelial nitric oxide synthase (eNOS) expression and nitric oxide (NO) production [1]. Administration of astragaloside IV (16, 32, and 64 μM) 1 h prior to lipopolysaccharide stimulation dose-dependently attenuated cardiac hypertrophy induced by lipopolysaccharide. Further studies demonstrated that astragaloside IV inhibited the increment of the resting intracellular free Ca2+, and its effect was similar to verapamil [2]. ASI could inhibit cells apoptosis induced by high glucose (25mmol/L) in dose-dependent and time-dependent manners. ASI also inhibited high glucose-induced expression of TGF-β1 and activation of p38 MAPK pathway at the protein level. Furthermore, ASI increased HGF production in human tubular epithelial cells [3].in vivo: the growth of tumor was suppressed by AS-IV treatment in vivo. AS-IV also could down-regulate regulatory T cells (Tregs) and up-regulate cytotoxic T lymphocytes (CTLs) in vivo and in vitro[4]. As an in vivo model, mice subjected to unilateral ureteral obstruction (UUO) were administered AS-IV (20 mg/kg) by intraperitoneal injection for 7 days. AS-IV significantly alleviated renal mass loss and reduced the expression of α-smooth muscle actin, fibronectin, and collagen IV both in vitro and in vivo [5]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 895.7±65.0 °C at 760 mmHg |
| Melting Point | 284-286ºC |
| Molecular Formula | C41H68O14 |
| Molecular Weight | 784.970 |
| Flash Point | 495.5±34.3 °C |
| Exact Mass | 784.460938 |
| PSA | 228.22000 |
| LogP | 1.96 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.621 |
| Storage condition | 2~8℃ |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2932999099 |
|
~%
83207-58-3 |
| Literature: Chemical and Pharmaceutical Bulletin, , vol. 31, # 2 p. 716 - 722 |
|
~%
83207-58-3 |
| Literature: Chemical and Pharmaceutical Bulletin, , vol. 31, # 2 p. 709 - 715 |
|
~%
83207-58-3 |
| Literature: Chemical and Pharmaceutical Bulletin, , vol. 31, # 2 p. 698 - 708 |
|
~%
83207-58-3 |
| Literature: Chemical and Pharmaceutical Bulletin, , vol. 31, # 2 p. 698 - 708 |
|
~%
83207-58-3 |
| Literature: Chemical and Pharmaceutical Bulletin, , vol. 31, # 2 p. 698 - 708 |
|
~%
83207-58-3 |
| Literature: Chemical and Pharmaceutical Bulletin, , vol. 31, # 2 p. 698 - 708 |
|
~%
83207-58-3 |
| Literature: Chemical and Pharmaceutical Bulletin, , vol. 31, # 2 p. 698 - 708 |
|
~%
83207-58-3 |
| Literature: Chemistry of Natural Compounds, , vol. 40, # 1 p. 40 - 44 |
| Precursor 7 | |
|---|---|
| DownStream 2 | |
| HS Code | 2932999099 |
|---|---|
| Summary | 2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |